Aurobindo Pharma | Biaya Operasional



Operating Expenses Perubahan Tanggal
Cipla INR 53.64B 164.8M 2024-12
Dr.Reddys Laboratories INR 69.85B 4.98B 2025-03
Hindustan Unilever INR 121.74B 4.02B 2025-03
Sun Pharmaceuticals INR 104.3B 3.51B 2024-12
UPL INR 95.09B 7.11B 2024-12



Aurobindo Pharma Biaya Operasional - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.